✦ LIBER ✦

A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer

✍ Scribed by Ho, Alan L.; Lipson, Brynna L.; Sherman, Eric J.; Xiao, Han; Fury, Matthew G.; Apollo, Arlyn; Seetharamu, Nagashree; Sima, Camelia S.; Haque, Sofia; Lyo, John K.; Sales, Roberta; Cox, Lisa; Pfister, David G.

Book ID: 121543526
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 180 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0073-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9086 Pralatrexate plus vitamin B12 and f

9086 Pralatrexate plus vitamin B12 and folic acid supplementation in patients with previously-treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial

✍ Azzoli, C.G.; Patel, J.; Krug, L.M.; Miller, V.; Subzwari, S.; Tyson, L.; Dunne, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Erlotinib and bevacizumab in patients wi

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

A phase II study of temsirolimus and erl

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

✍ Bauman, Julie E.; Arias-Pulido, Hugo; Lee, Sang-Joon; Fekrazad, M. Houman; Ozawa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 496 KB

A randomized phase II study of docetaxel

A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

✍ Limaye, Sewanti; Riley, Sarah; Zhao, Sihai; O’Neill, Anne; Posner, Marshall; Adk 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 375 KB

A phase 2 study of pemetrexed plus gemci

A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer

✍ Matthew G. Fury; Sofia Haque; Hilda Stambuk; Ronglai Shen; Diane Carlson; David 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB